组织因子通路抑制剂作为潜在的目标,以了解孕前的病理生理学
Hiroshi Kobayashi1,2, Sho Matsubara2,3, Chiharu Yoshimoto2,4
1Department of Gynecology and Reproductive Medicine, Ms.Clinic MayOne, 871-1 Shijo-cho, Kashihara 634-0813, Japan.
Biomedicines
|May 27, 2023
概括
组织因子通路抑制剂1 (TFPI1) 和TFPI2在怀孕中起着至关重要的作用. 在孕前症中,TFPI1和TFPI2的水平变化表明它们有可能成为这种高血压疾病的生物标志物.
科学领域:
- 生殖生物学 生殖生物学
- 血液学 血液学 血液学
- 产科 产科 产科 产科 产科
背景情况:
- 孕前是一种全球性高血压疾病,导致显著的孕产妇和产周死亡率.
- 它涉及到凝血和纤维解的复杂干扰,组织因子通路抑制剂 (TFPI) 起着关键作用.
- 在孕前症中TFPI1和TFPI2的特定作用仍未得到充分研究.
研究的目的:
- 审查TFPI1和TFPI2.2的生物功能.
- 讨论它们对孕前的影响.
- 探索未来的研究方向.
主要方法:
- 进行了全面的文献搜索.
- 搜索的数据库包括PubMed和谷歌学者.
- 搜索涵盖了从创立到2022年6月30日的文献.
主要成果:
- TFPI1和TFPI2表现出不同的蛋白酶抑制活性.
- TFPI1 抑制了外部凝固途径,而 TFPI2 具有抗纤维解质作用,并促进了高凝固状态.
- 此外,TFPI2抑制了热囊细胞的入侵,并促进了亡,与TFPI1的作用形成鲜明对比.
- 在产前症中,母亲的血液和胎盘TF,TFPI1和TFPI2度发生变化.
结论:
- TFPI蛋白家族对抗凝血剂 (TFPI1) 和抗纤维解质/凝血剂 (TFPI2) 系统都有影响.
- TFPI1和TFPI2显示出作为产前的预测生物标志物的潜力.
- 这些发现可能有助于开发精确治疗子宫前的准确疗法.
相关概念视频
01:24Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
01:16Clot Retraction and Fibrinolysis
6.6K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.6K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
773
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
773
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
8.5K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.5K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
570
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
570